Population/Individual Bioequivalence [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2015-02-02 14:30 (3735 d 19:39 ago) – Posting: # 14352
Views: 9,084

Hi Kaushik,

❝ I have read in a BEBAC forum posted by HS that the concept of Individual/Population Bioequivalence is no longer considered by FDA/other regulatory agencies, Is it true?


AFAIK, yes.

❝ Finally, I would like to hear […] about the status of IBE/PBE statistical analysis, Does it have any relevance now?


No. If the FDA is concerned, parts of the methodology enter the scene through the back door, e.g., com­paring within-subject variances of NTIDs (warfarin guidance) and the subject-by-formulation inter­action (ER methylphenidate guidance).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
24 visitors (0 registered, 24 guests [including 1 identified bots]).
Forum time: 11:09 CEST (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5